Online inquiry

IVTScrip™ mRNA-Human ARFIP2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK23173MR)

This product GTTS-WK23173MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARFIP2 protein. This product can be used in SLC16A7+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001242854.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23647
UniProt ID P53365
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARFIP2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK23173MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK28267MR IVTScrip™ mRNA-Human ARF5, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARF5
GTTS-WK26893MR IVTScrip™ mRNA-Human ASB1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ASB1
GTTS-WK2333MR IVTScrip™ mRNA-Human GCET2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA GCET2
GTTS-WK25097MR IVTScrip™ mRNA-Human ASB16-AS1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ASB16-AS1
GTTS-WK20620MR IVTScrip™ mRNA-Human ANKRD36B, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD36B
GTTS-WK22602MR IVTScrip™ mRNA-Human ARHGAP8, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP8
GTTS-WK21869MR IVTScrip™ mRNA-Human ATN1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ATN1
GTTS-WK11330MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Additional GABA Compounds
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW